In their study, Shi et al. found that fraxinellone downregulates SIRT3 expression in GBM cells, suggesting SIRT3’s significant role in GBM progression, as its reduction inhibits cell proliferation and migration [91]. The gene discussed is SIRT3; the disease is glioblastoma.